Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey

Journal of Clinical Epidemiology

Volumn 87, Issue , 2017, Pages 78-86

  Hakoum, Maram B ^a   Jouni, Nahla ^a   Abou Jaoude, Eliane A ^b   Hasbani, Divina Justina ^a   Abou Jaoude, Elias A ^b   Lopes, Luciane Cruz ^c   Khaldieh, Mariam ^a   Hammoud, Mira Z ^d   Al Gibbawi, Mounir ^a   Anouti, Sirine ^a   Guyatt, Gordon ^e   Akl, Elie A ^a,e  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY OF SOROCABA   (Brazil)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Bias; Conflict of interest; ICMJE; Randomized controlled trial; Reporting; Trial author

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; DESCRIPTIVE RESEARCH; FUNDING; INTERPERSONAL COMMUNICATION; JOURNAL IMPACT FACTOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE; HUMAN; INCOME; MEDICAL RESEARCH; PUBLICATION; STATISTICS AND NUMERICAL DATA; WRITING;

AUTHORSHIP; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DISCLOSURE; HUMANS; INCOME; PERIODICALS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85019419217     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2017.04.002     Document Type: Article

References (48)

1. Schunemann, H.J., Osborne, M., Moss, J., Manthous, C., Wagner, G., Sicilian, L., et al. An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med 180 (2009), 564–580.
2. Guyatt, G., Akl, E.A., Hirsh, J., Kearon, C., Crowther, M., Gutterman, D., et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 152 (2010), 738–741.
3. Akl, E.A., Karl, R., Guyatt, G.H., Methodologists and context experts disagreed regarding managing conflicts of interest of clinical practice guidelines panels. J Clin Epidemiol 65 (2012), 734–739.
4. Norris, S.L., Burda, B.U., Holmer, H.K., Ogden, L.A., Fu, R., Bero, L., et al. Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol 65 (2012), 725–733.
5. Neumann, I., Karl, R., Rajpal, A., Akl, E.A., Guyatt, G.H., Experiences with a novel policy for managing conflicts of interest of guideline developers: a descriptive qualitative study. Chest 144 (2013), 398–404.
6. Akl, E.A., El-Hachem, P., Abou-Haidar, H., Neumann, I., Schunemann, H.J., Guyatt, G.H., Considering intellectual, in addition to financial, conflicts of interest proved important in a clinical practice guideline: a descriptive study. J Clin Epidemiol 67 (2014), 1222–1228.
7. Viswanathan, M., Carey, T.S., Belinson, S.E., Berliner, E., Chang, S.M., Graham, E., et al. A proposed approach may help systematic reviews retain needed expertise while minimizing bias from nonfinancial conflicts of interest. J Clin Epidemiol 67 (2014), 1229–1238.
8. Schunemann, H.J., Al-Ansary, L.A., Forland, F., Kersten, S., Komulainen, J., Kopp, I.B., et al. Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines. Ann Intern Med 163 (2015), 548–553.
9. Agoritsas, T., Neumann, I., Mendoza, C., Guyatt, G.H., Guideline conflict of interest management and methodology heavily impacts on the strength of recommendations: comparison between two iterations of the American College of Chest Physicians Antithrombotic Guidelines. J Clin Epidemiol, 2016.
10. Kjaergard, L.L., Als-Nielsen, B., Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ, 325, 2002, 249.
11. Perlis, C.S., Harwood, M., Perlis, R.H., Extent and impact of industry sponsorship conflicts of interest in dermatology research. J Am Acad Dermatol 52 (2005), 967–971.
12. Jagsi, R., Sheets, N., Jankovic, A., Motomura, A.R., Amarnath, S., Ubel, P.A., Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer 115 (2009), 2783–2791.
13. Brignardello-Petersen, R., Carrasco-Labra, A., Yanine, N., Ulloa, C., Araya, I., Pintor, F., et al. Positive association between conflicts of interest and reporting of positive results in randomized clinical trials in dentistry. J Am Dent Assoc 144:10 (2013), 1165–1170.
14. Vera-Badillo, F.E., Napoleone, M., Krzyzanowska, M.K., Alibhai, S.M., Chan, A.W., Ocana, A., et al. Bias in reporting of randomised clinical trials in oncology. Eur J Cancer 61 (2016), 29–35.
15. Rasmussen, K., Schroll, J., Gotzsche, P.C., Lundh, A., Under-reporting of conflicts of interest among trialists: a cross-sectional study. J R Soc Med 108:3 (2015), 101–107.
16. Roseman, M., Milette, K., Bero, L.A., Coyne, J.C., Lexchin, J., Turner, E.H., et al. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 305 (2011), 1008–1017.
17. Roseman, M., Turner, E.H., Lexchin, J., Coyne, J.C., Bero, L.A., Thombs, B.D., Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study. BMJ, 345, 2012, e5155.
18. Carragee, E.J., Hurwitz, E.L., Weiner, B.K., A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11:6 (2011), 471–491.
19. Tuech, J.J., Moutel, G., Pessaux, P., Thoma, V., Schraub, S., Herve, C., Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Eur J Cancer 41:15 (2005), 2237–2240.
20. Riechelmann, R.P., Wang, L., O'Carroll, A., Krzyzanowska, M.K., Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology. J Clin Oncol 25 (2007), 4642–4647.
21. Rising, K., Bacchetti, P., Bero, L., Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med, 5(11), 2008, e217 discussion e217.
22. Klitzman, R., Chin, L.J., Rifai-Bishjawish, H., Kleinert, K., Leu, C.-S., Disclosures of funding sources and conflicts of interest in published HIV/AIDS research conducted in developing countries. J Med Ethics 36 (2010), 505–510.
23. Forbes, T.L., Author disclosure of conflict of interest in vascular surgery journals. J Vasc Surg 54:3 Suppl (2011), 55S–58S.
24. Aneja, A., Esquitin, R., Shah, K., Iyengar, R., Nisenbaum, R., Melo, M., et al. Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials. J Am Coll Cardiol 61 (2013), 1137–1143.
25. Bariani, G.M., de Celis Ferrari, A.C., Hoff, P.M., Krzyzanowska, M.K., Riechelmann, R.P., Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology. J Clin Oncol 31 (2013), 2289–2295.
26. Beyari, M.M., Hak, A., Li, C.S., Lamfon, H.A., Conflict of interest reporting in dentistry randomized controlled trials: a systematic review. J Evid Based Dent Pract 14:4 (2014), 158–164.
27. Bridoux, V., Moutel, G., Schwarz, L., Michot, F., Herve, C., Tuech, J.J., Disclosure of funding sources and conflicts of interest in phase III surgical trials: survey of ten general surgery journals. World J Surg 38 (2014), 2487–2493.
28. Froud, R., Bjorkli, T., Bright, P., Rajendran, D., Buchbinder, R., Underwood, M., et al. The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression. BMC Musculoskelet Disord, 16, 2015, 370.
29. Pang, W.K., Yeter, K.C., Torralba, K.D., Spencer, H.J., Khan, N.A., Financial conflicts of interest and their association with outcome and quality of fibromyalgia drug therapy randomized controlled trials. Int J Rheum Dis 18:6 (2015), 606–615.
30. Voineskos, S.H., Coroneos, C.J., Ziolkowski, N.I., Kaur, M.N., Banfield, L., Meade, M.O., et al. A systematic review of surgical randomized controlled trials: part 2. Funding source, conflict of interest, and sample size in plastic surgery. Plast Reconstr Surg 137 (2016), 453e–461e.
31. Hakoum, M.B., Anouti, S., Al-Gibbawi, M., Abou-Jaoude, E.A., Hasbani, D.J., Lopes, L.C., et al. Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey. BMJ Open, 6(8), 2016, e011997.
32. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med 3:3 (2009), e123–e130.
33. Harris, P.A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J.G., Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:2 (2009), 377–381.
34. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Table 8.5.d: criteria for judging risk of bias in the ‘Risk of bias’ assessment tool. The Cochrane Collaboration, 2011.
35. Shawwa, K., Kallas, R., Koujanian, S., Agarwal, A., Neumann, I., Alexander, P., et al. Requirements of clinical journals for authors' disclosure of financial and non-financial conflicts of interest: a cross sectional study. PLoS One, 11, 2016, e0152301.
36. Bindslev, J.B., Schroll, J., Gotzsche, P.C., Lundh, A., Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study. BMC Med Ethics, 14, 2013, 19.
37. Hannon, C.P., Chalmers, P.N., Carpiniello, M.F., Cvetanovich, G.L., Cole, B.J., Bach, B.R. Jr, Inconsistencies between physician-reported disclosures at the AAOS annual meeting and industry-reported financial disclosures in the open payments database. J Bone Joint Surg Am, 98, 2016, e90.
38. Mitchell, A.P., Basch, E.M., Dusetzina, S.B., Financial relationships with industry among national comprehensive cancer network guideline authors. JAMA Oncol 2:12 (2016), 1628–1631.
39. Ahn, R., Woodbridge, A., Abraham, A., Saba, S., Korenstein, D., Madden, E., et al. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study. BMJ, 356, 2017, i6770.
40. Ancker, J.S., Flanagin, A., A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 13:2 (2007), 147–157.
41. Probst, P., Huttner, F.J., Klaiber, U., Diener, M.K., Buchler, M.W., Knebel, P., Thirty years of disclosure of conflict of interest in surgery journals. Surgery 157 (2015), 627–633.
42. Rowan-Legg, A., Weijer, C., Gao, J., Fernandez, C., A comparison of journal instructions regarding institutional review board approval and conflict-of-interest disclosure between 1995 and 2005. J Med Ethics 35 (2009), 74–78.
43. Montori, V.M., Jaeschke, R., Schunemann, H.J., Bhandari, M., Brozek, J.L., Devereaux, P.J., et al. Users' guide to detecting misleading claims in clinical research reports. BMJ 329 (2004), 1093–1096.
44. Danish Medicines Agency. List of proprietary pharmacists, doctors, nurses and dentists who have a relationship with a company, Available at https://laegemiddelstyrelsen.dk/en/licensing/collaboration-with-companies/relationships/lists/proprietary-pharmacists,-doctors,-nurses-and-dentists/. Accessed April 30, 2017.
45. Centers for Medicare & Medicaid Services. Open Payments. 2014 Available at https://www.cms.gov/openpayments/ Accessed March 6, 2017.
46. Moher, D., Hopewell, S., Schulz, K.F., Montori, V., Gotzsche, P.C., Devereaux, P.J., et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 63 (2010), e1–e37.
47. Schulz, K.F., Altman, D.G., Moher, D., CONSORT Group, CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 63 (2010), 834–840.
48. Lenzer, J., When is a point of view a conflict of interest?. BMJ, 355, 2016, i6194.